Cargando…
Role of left atrial appendage occlusion in patients with HeartMate 3
OBJECTIVES: Left atrial appendage occlusion (LAAO) at the time of implantation may reduce thromboembolic events (TEs) during continuous-flow left ventricular assist device support. The HeartMate 3 (HM3) reduces TEs overall, but the efficacy of LAAO in HM3 is unknown. METHODS: Adults receiving first...
Autores principales: | Melehy, Andrew, O’Connell, Gillian, Ning, Yuming, Kurlansky, Paul, Kaku, Yuji, Topkara, Veli, Yuzefpolskaya, Melana, Colombo, Paolo C, Sayer, Gabriel, Uriel, Nir, Naka, Yoshifumi, Takeda, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972327/ https://www.ncbi.nlm.nih.gov/pubmed/34662395 http://dx.doi.org/10.1093/icvts/ivab285 |
Ejemplares similares
-
Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib
por: Lotan, Dor, et al.
Publicado: (2022) -
Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3
por: Hayashi, Hideyuki, et al.
Publicado: (2021) -
Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size
por: Tonai, Kohei, et al.
Publicado: (2022) -
The Impact of Intrapericardial versus Intrapleural HeartMate 3 Pump Placement on Clinical Outcomes
por: Salna, Michael, et al.
Publicado: (2022) -
Does lateral approach preserve the right ventricular function after HeartMate 3 insertion?
por: Hayashi, Hideyuki, et al.
Publicado: (2023)